Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Xperi Holding Corporation is a semiconductor equipment & materials business based in the US. Xperi Holding Corporation shares (XPER) are listed on the NASDAQ and all prices are listed in US Dollars. Xperi Holding Corporation employs 1,800 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$18.16|
|52-week range||$12.10 - $24.91|
|50-day moving average||$19.53|
|200-day moving average||$20.74|
|Wall St. target price||$28.00|
|Dividend yield||$0.2 (1.06%)|
|Earnings per share (TTM)||$1.43|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-15)||-2.47%|
|1 month (2021-09-23)||-6.15%|
|3 months (2021-07-23)||-11.89%|
|6 months (2021-04-23)||-14.28%|
|1 year (2020-10-23)||42.43%|
|2 years (2019-10-23)||-11.59%|
|3 years (2018-10-23)||37.68%|
|5 years (2016-10-21)||37.3|
Valuing Xperi Holding Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Xperi Holding Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Xperi Holding Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 13x. In other words, Xperi Holding Corporation shares trade at around 13x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Xperi Holding Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.08. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Xperi Holding Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Xperi Holding Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $494.3 million.
The EBITDA is a measure of a Xperi Holding Corporation's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$1.1 billion|
|Operating margin TTM||24.39%|
|Gross profit TTM||$813.7 million|
|Return on assets TTM||6.18%|
|Return on equity TTM||10.83%|
|Market capitalisation||$2 billion|
TTM: trailing 12 months
There are currently 3.6 million Xperi Holding Corporation shares held short by investors – that's known as Xperi Holding Corporation's "short interest". This figure is 0.4% up from 3.6 million last month.
There are a few different ways that this level of interest in shorting Xperi Holding Corporation shares can be evaluated.
Xperi Holding Corporation's "short interest ratio" (SIR) is the quantity of Xperi Holding Corporation shares currently shorted divided by the average quantity of Xperi Holding Corporation shares traded daily (recently around 456639.39008895). Xperi Holding Corporation's SIR currently stands at 7.87. In other words for every 100,000 Xperi Holding Corporation shares traded daily on the market, roughly 7870 shares are currently held short.
However Xperi Holding Corporation's short interest can also be evaluated against the total number of Xperi Holding Corporation shares, or, against the total number of tradable Xperi Holding Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Xperi Holding Corporation's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Xperi Holding Corporation shares in existence, roughly 30 shares are currently held short) or 0.035% of the tradable shares (for every 100,000 tradable Xperi Holding Corporation shares, roughly 35 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Xperi Holding Corporation.
Find out more about how you can short Xperi Holding Corporation stock.
Dividend payout ratio: 5.73% of net profits
Recently Xperi Holding Corporation has paid out, on average, around 5.73% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.06% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Xperi Holding Corporation shareholders could enjoy a 1.06% return on their shares, in the form of dividend payments. In Xperi Holding Corporation's case, that would currently equate to about $0.2 per share.
While Xperi Holding Corporation's payout ratio might seem low, this can signify that Xperi Holding Corporation is investing more in its future growth.
Xperi Holding Corporation's most recent dividend payout was on 13 September 2021. The latest dividend was paid out to all shareholders who bought their shares by 22 August 2021 (the "ex-dividend date").
Over the last 12 months, Xperi Holding Corporation's shares have ranged in value from as little as $12.1043 up to $24.9102. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Xperi Holding Corporation's is 0.7751. This would suggest that Xperi Holding Corporation's shares are less volatile than average (for this exchange).
Xperi Holding Corporation, together with its subsidiaries, operates as a consumer and entertainment product/solutions licensing company worldwide. It operates through two segments, Product, and Intellectual Property Licensing. The company invents, develops, and delivers various technologies. It licenses audio, digital radio, imaging, edge-based machine learning, and multi-channel video user experience solutions to consumer electronics customers, automotive manufacturers, or supply chain partners. The company also provides licensing to multichannel video programming distributors, OTT video service providers, consumer electronics manufacturers, social media, and other new media companies in media industry; and memory, sensors, RF component, and foundry companies in semiconductor industry. It provides its technologies under the DTS, HD Radio, IMAX Enhanced, Invensas, TiVo, and Perceive brands. The company is headquartered in San Jose, California.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.